We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
THE LEE COMPANY

Download Mobile App




AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

By LabMedica International staff writers
Posted on 21 Nov 2023
Print article
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated from these images. Researchers are often overwhelmed with the task of analyzing data from hundreds of molecules across tens of thousands of cells. While artificial intelligence (AI) offers a potential solution to manage this deluge of information, traditional AI methods like deep neural networks often operate as a 'black box,' providing results without transparent or comprehensible explanations. To address this, scientists are now looking towards AI techniques from other disciplines to develop new methods for interpreting tumor images.

Researchers at Karolinska Institutet (Stockholm, Sweden) and SciLifeLab (Solna, Sweden) have adopted AI strategies commonly used in satellite imaging and community ecology to manage and understand complex data from tumor tissues. Their work, detailed in the journal Nature Communications, could pave the way for more tailored cancer treatments. AI methods are already being used to categorize and identify various geographic features in satellite imagery, such as cities, bodies of water, and different types of landscapes. In the field of ecology, sophisticated analytical methods are employed to understand how different species coexist within specific environments.

Recognizing parallels between these fields and tumor analysis, the researchers applied similar techniques to the study of cancerous tissues. The methods used in satellite imagery and ecology have been adapted to analyze the intricate dynamics of tumor tissues. This approach has transformed complex datasets into valuable insights about the nature of cancer. The next phase involves applying this novel method in clinical trials. The research team is collaborating with a major cancer center to determine why only certain patients respond to immunotherapy for cancer. Additionally, they are investigating why some patients with breast cancer may not require chemotherapy. This innovative use of AI in cancer research holds promise for enhancing our understanding of cancer and improving patient outcomes.

“With our new method, we can reveal important details in tumour tissue that can determine whether a cancer treatment works or not. The long-term goal is to be able to tailor cancer treatments to individual needs and avoid unnecessary side effects,” said Jean Hausser, senior researcher at the Department of Cell and Molecular Biology, Karolinska Institutet, who led the research.

Related Links:
Karolinska Institutet
SciLifeLab

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
New
Gold Supplier
Spinal Fluid Cell Count Control
Spinalscopics
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
ELISA & CLIA Analyzer
Autoplex G3

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Industry

view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.